Browsing: Cancer

In an unprecedented and strategic move, the U.S. Food and Drug Administration (FDA) has granted permission for the temporary import of an unapproved Chinese cancer drug. The decision comes amid a growing shortage of vital cancer drugs in the US, notably cisplatin, a widely used chemotherapy medication. The crisis has prompted the FDA to consider unconventional approaches, and this move stands as testament to that flexibility.

Retiree J.F. Lian’s battle with skin cancer in 2022 led to a life-altering surgery that removed most of his external nose. Accustomed to the gaping void on his face, he accepted it as his new reality. However, a revolutionary proposal from Tan Tock Seng Hospital (TTSH) in Singapore offered a new path forward.

Endocrine-disrupting chemicals (EDCs) are a silent menace that infiltrate our daily lives, impacting our health in subtle yet significant ways. These stealthy substances can interfere with our hormonal balance, leading to a myriad of health issues. In Asia, where rapid industrialisation and urbanisation have intensified the presence of EDCs, understanding their sources, effects, and ways to reduce exposure is crucial. This article delves into the world of endocrine disruptors and their impact on Asia’s health landscape.

CytoMed Therapeutics has developed a revolutionary new cancer treatment that uses modified white blood cells from healthy donors to recognize and destroy cancer cells. The therapy is being trialled in Singapore on patients with the most common types of cancer. If successful, the treatment could lead to more efficient and accessible CAR-T cell therapies for a range of solid and blood cancers.